Clinical implications of the presence of hepatitis C virus antibodies after kidney transplantation: results of a study using second-generation assays for anti-HCV.
Tomikawa
S
S
Department of Surgery, University of Tokyo, Japan.
Uchida
H
H
Nagao
T
T
Beck
Y
Y
Degawa
H
H
Watanabe
K
K
Nishimura
Y
Y
Nomura
Y
Y
Ichikawa
N
N
Kikuchi
K
K
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D018937:Hepatitis C Antibodies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D012263:Ribonucleosides / Q000627:therapeutic use; D013997:Time Factors
D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D001379:Azathioprine